Pathophysiology of pre-eclampsia: Update on the role of nitric oxide

Current Hypertension Reports

Volumn 5, Issue 6, 2003, Pages 493-497

  Kashiwagi, Maki ^a   Zimmermann, Roland ^a   Beinder, Ernst ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

CHRONIC DISEASE; ECLAMPSIA; HUMAN; MATERNAL HYPERTENSION; PATHOPHYSIOLOGY; PREECLAMPSIA; PROPHYLAXIS; REVIEW; RISK FACTOR;

EID: 3142624748     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-003-0057-2     Document Type: Review

References (49)

1. Roberts JM, Pearson G, Cutler J, et al.: Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003, 41:437-45.
2. Sibai BM: Chronic hypertension in pregnancy. Obstet Gynecol 2002, 100:369-377.
3. Brown MA, Lindheimer MD, de Swiet M, et al.: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregn 2001, 20:IX-XIV.
4. Hallak M: Hypertension in pregnancy. In High Risk Pregnancy. Management Options. Edited by James DK, Steer PJ, Weiner CP, et al. Philadelphia: WB Saunders; 1999:639-663.
5. Zhang J, Klebanoff MA, Roberts JM: Prediction of adverse outcomes by common definitions of hypertension in pregnancy. Obstet Gynecol 2001, 97:261-267.
6. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000, 183:S1-S22.
7. Sibai BM, Gordon T, Thom E, et al.: Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995, 172:642-648.
8. Seligman S: Which blood pressure? Br J Obstet Gynaecol 1987, 94:497-498.
9. Weinstein L: Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982, 142:159-167.
10. Sibai BM: The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 1990, 162:311-316.
11. Shembrey MA, Noble AD: An instructive case of abdominal pregnancy. Aust N Z J Obstet Gynaecol 1995, 35:220-221.
12. Page E: The relation between hydatidiform moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol 1939, 37:291-293.
13. Roberts JM, Lain KY: Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002, 23:359-372.
14. Baylis C, Beinder E, Suto T, et al.: Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy. Semin Nephrol 1998, 18:208-230.
15. Scalera F, Schlembach D, Beinder E: Production of vasoactive substances by human umbilical vein endothelial cells after incubation with serum from preeclamptic patients. Eur J Obstet Gynecol Reprod Biol 2001, 99:172-178.
16. Savvidou MD, Hingorani A, Tsikas D, et al.: Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003, 361:1511-17.
17. Clark SL, Cotton DB, Lee W, et al.: Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol 1989, 161:1439-1442.
18. Roberts M, Lindeheimer MD Davison JM: Altered glomerular permselectivity to neutral dextrans and heteroporous membrane modeling in human pregnancy, Am J Physiol 1996, 270(2Pt2):F338-F343.
19. Baylis C: Glomerular filtration and volume regulation in gravid animal models. Bailliere's Clin Obstet Gynaecol 1994, 8:235-264.
20. Cotton D, Lee W, Huhta J, et al.: Hemodynamic profile of severe pregnancy-induced hypertension. Am J Obstet Gynecol 1988, 158:523-529.
21. Groenendijk R, Trimbos JB, Wallenburg HC: Hemodynamic measurements in preeclampsia: preliminary observations. Am J Obstet Gynecol 1984, 150:232-236.
22. Brown M, Zammit V, Mitar D: Extracellular fluid volume in pregnancy-induced hypertension. J Hypertens 1992, 10:61-68.
23. Zhou Y, Damsky CH, Fisher SJ: Preeclampsia is associated with failure of human cytotrophoblasts; to mimic a vascular adhesion phenotype: one cause of defective endovascular invasion in this syndrome? J Clin Invest 1997, 99:2152-2164.
24. Reister F, Frank HG, Kingdom JC, et al.: Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 2001, 81:1143-1152.
25. Taylor RN, Grimwood J, Taylor RS, et al.: Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003, 188:177-182.
26. Genbacev O, Zhou Y, Ludlow JW, et al.: Regulation of human placental development by oxygen tension. Science 1997, 277:1669-1672.
27. Kashiwagi M, Breymann C, Huch R, et al.: Hypertension in a pregnancy with renal anemia after recombinant human erythropoietin (rhEPO) therapy. Arch Gynecol Obstet 2002, 267:54-56.
28. Ong SS, Crocker IP, Warren AY, et al.: Functional characteristics of chorionic plate placental arteries from normal pregnant women and women with pre-eclampsia. Hypertens Pregnancy 2002, 21:175-183.
29. King RG, Gude NM, Di Iulio JL, et al.: Regulation of human placental fetal vessel tone: role of nitric oxide. Reprod Fertil Dev 1995, 7:1407-1411.
30. Walsh SW: Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985, 152:335-340.
31. Chavarria ME, Lara-Gonzalez L, Gonzalez-Gleason A, et al.: Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia. Am J Obstet Gynecol 2003, 188:986-992.
32. Scalera F, Dittrich R, Beckmann MW, et al.: Effect of endothelin-1 on intracellular glutathione and lipid peroxide availability and on the secretion of vasoactive substances by human umbilical vein endothelial cells. Eur J Clin Invest 2002, 32:556-562.
33. Cockell AP, Poston L: Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension 1997, 30:247-251.
34. Li H, Wallerath T, Forstermann U: Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide 2002, 7:132-147.
35. Sladek SM, Magness RR, Conrad KP: Nitric oxide and pregnancy. Am J Physiol 1997, 272:R441-R463.
36. Seligman SP, Buyon JP, Clancy RM, et al.: The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994, 171:944-948.
37. Williams DJ, Vallance PJ, Neild GH, et al.: Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol 1997, 272:H748-H752.
38. Conrad KP, Joffe GM, Kruszyna H, et al.: Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993, 7:566-571.
39. Myatt L, Brewer AS, Langdon G, et al.: Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. Am J Obstet Gynecol 1992, 166:224-230.
40. Cadnapaphornchai MA, Ohara M, Morris KG Jr, et al.: Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy. Am J Physiol Renal Physiol 2001, 280:F592-F598.
41. Diket AL, Pierce MR, Munshi UK, et al.: Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol 1994, 171:1243-1250.
42. Yallampalli C, Garfield RE: Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993, 169:1316-1320.
43. Salas SP, Altermatt F, Campos M, et al.: Effects of long-term nitric oxide synthesis inhibition on plasma volume expansion and fetal growth in the pregnant rat. Hypertension 1995, 26:1019-1023.
44. Molnar M, Suto T, Toth T, et al.: Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 1994, 170:1458-1466.
45. Ramsay B, Sooranna SR, Johnson MR: Nitric oxide synthase activities in human myometrium and villous trophoblast throughout pregnancy. Obstet Gynecol 1996, 87:249-253.
46. Beinder E, Mohaupt MG, Schlembach D, et al.: Nitric oxide synthase activity and Doppler parameters in the fetoplacental and uteroplacental circulation in preeclampsia. Hypertens Pregn 1999, 18:115-127.
47. Shaamash AU, Elsnosy ED, Makhlouf AM, et al.: Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia. Int J Gynaecol Obstet 2000, 68:207-214.
48. Rajagopal M, Moodley J, Chetty R: Nitric oxide: Does it have an etiological role in pre-eclampsia? Acta Obstet Gynecol Scand 2003, 82:216-219.
49. Nakatsuka M, Takata M, Tada K, et al.: A long-term transdermal nitric oxide donor improves uteroplacental circulation in women with preeclampsia. J Ultrasound Med 2002, 21:831-836.